The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma

Annals of Allergy, Asthma and Immunology

Volumn 82, Issue 4, 1999, Pages 383-389

  Condemi, John J ^a   Goldstein, Stanley ^b   Kalberg, Christopher ^c   Yancey, Steven ^c   Emmett, Amanda ^c   Rickard, Kathleen ^c  

^a Allergy Asthma Immunology of Rochester   (United States)

^b Island Medical Research   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE; FLUTICASONE PROPIONATE; PLACEBO; SALBUTAMOL; SALMETEROL;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HEPATITIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; IRRITABILITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PERICARDITIS; PNEUMONIA; PRIORITY JOURNAL; VERTIGO;

EID: 0032906413     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63288-7     Document Type: Article

References (14)

1. National Asthma Education and Prevention Program. Expert Panel Report 2: guidelines for the diagnosis and management of asthma. NIH Publication No. 97-4051, 1997.
2. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-224.
3. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488.
4. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-1218.
5. Ukena D, Harnest U, Sakalauskas R, et al. Comparison of addition of theophylline to inhaled steroids with doubling the dose of inhaled steroid in asthma. Eur Respir J 1997;10:2754-2760.
6. Evans DJ, Taylor DA, Zetterstorm O, et al. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-1418.
7. Product Information, Flovent® (fluticasone propionate) Inhalation Aerosol, July 1997.
8. Phillips GW. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990;84(suppl):19-23.
9. -1) administered by pressurized inhaler. Respir Med 1993;87:609-620.
10. Leblanc P, Mink S, Keistinen T, et al. A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthma. Allergy 1994;49:380-385.
11. Raphael GD, Baker JW, Chervinsky P, et al. Low dose fluticasone propionate (FP) is more effective than higher doses of beclomethasone dipropionate (BDP) in patients with mild to moderate asthma. J Allergy Clin Immunol 1998;10:S6.
12. Paulwels RA, Lofdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. New Eng J Med 1997;337:1405-1411.
13. Kemp J, Kalberg C, Anderson W, et al. Effect of 24-week salmeterol therapy on hyperresponsiveness. Am J Respir Crit Care Med 1997;55:A344.
14. Wilding P, Clark M, Coon JT, et al. Effect of long term treatment with salmeterol on asthma control: a double blind, randomised crossover study. Brit Med J 1997;314:1441-1460.